{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:07:52Z","timestamp":1793336872650,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Xuebijing injection (XBJI), as a Chinese patent medicine injection, consists of five botanical drugs for anti-inflammatory treatment. Acute pancreatitis (AP) is induced by localized inflammation, potentially resulting in multiple organ dysfunction syndromes, specifically including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Recent studies suggest that XBJI effective in alleviating potentially easing ALI and ARDS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We illustrated the efficacy and safety of XBJI for pulmonary function of AP by conducting a systematic literature review and meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted searches across eight databases, including PubMed, Embase, and the Cochrane Library, up to September 2024. Two independent investigators screened and selected the literature based on predefined inclusion and exclusion criteria, followed by data extraction. The quality of the selected studies was assessed using the Cochrane Collaboration\u2019s Risk of Bias 2.0 tool. The data were then qualitatively analyzed and synthesized by using Review Manager software, in accordance with the PRISMA guidelines and the Cochrane Handbook.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study showed that using conventional therapy combined with XBJI might increase the oxygenation index, lower the respiratory rate, and improve APACHE II scores and inflammatory biomarkers. However, there is a high risk of bias and the quality of the included studies is low. More well-designed, large-sample, and high-quality trials are needed to be conducted in multiple centers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1549419","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:26:52Z","timestamp":1744781212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Efficacy of Xuebijing injection on pulmonary ventilation improvement in acute pancreatitis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuling","family":"Bin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.1491","article-title":"Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome","volume":"202","author":"Bhatia","year":"2004","journal-title":"J. Pathol. Feb"},{"key":"B2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/s0140-6736(20)31310-6","article-title":"Acute pancreatitis","volume":"396","author":"Boxhoorn","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.14046\/j.cnki.zyytb2002.2019.03.012","article-title":"Clinical study of Xuebijing injection in the treatment of severe pancreatitis complicated with acute respiratory distress syndrome","volume":"18","author":"Chang Xiao","year":"2019","journal-title":"Bull. traditional Chin. Med."},{"key":"B4","first-page":"194","article-title":"Protective effect of Xuebijing on lung injury in rats with severe acute pancreatitis","volume":"24","author":"Chen","year":"2011","journal-title":"Med. Inf. (next issue)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-9905.2018.012.020","article-title":"Effect of Xuebijing Injection on oxidative stress and lung injury in patients with severe acute pancreatitis","author":"Chenjialian","year":"2018","journal-title":"Prog. Mod. general Surg. China.21"},{"key":"B6","article-title":"Protective effect of Xuebijing on lung function in patients with severe acute pancreatitis","volume":"2","year":"2011","journal-title":"Massage rehabilitation Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-1528.2020.11.039","article-title":"Effect of Xuebijing Injection on lung injury and expression of TLR4, NF-\u03baB and TNF-\u03b1 in lung tissue of acute pancreatitis rats","volume":"42","author":"Dong","year":"2020","journal-title":"Chin. Pat. Med."},{"key":"B8","first-page":"78","volume-title":"Clinical study of Xuebijing injection in the treatment of severe pancreatitis complicated with acute respiratory distress syndrome.","year":"2019"},{"key":"B9","first-page":"1214","article-title":"Zhu Jun. 2008. Clinical observation of Xuebijing in the treatment of acute pancreatitis complicated with lung injury","volume-title":"Chin. J. Prim. Med. Pharm.","author":"Feng Yan","year":""},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.11656\/j.issn.1672-1519.2022.09.08","article-title":"Protective effect and clinical efficacy of different doses of Xuebijing Injection on lung injury in patients with acute pancreatitis","volume":"39","author":"Ge Kaijie","year":"2022","journal-title":"Tianjin Tradit. Chin. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.joim.2024.08.006","article-title":"Clinical efficacy of Xuebijing injection for the treatment of sepsis: a retrospective cohort study","volume":"30","author":"Gong","year":"2024","journal-title":"J. Integr. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.21037\/apm-20-1478","article-title":"Xuebijing injection in the treatment of COVID-19: a retrospective case-control study","volume":"9","author":"Guo","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00000658-197701000-00007","article-title":"Acute pancreatitis: analysis of factors influencing survival","volume":"185","author":"Jacobs","year":"1977","journal-title":"Ann. Surg."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1674-1935.2010.06.019","article-title":"Expression of Toll-like receptor 4\/NF-\u03baB signal transduction pathway in pulmonary injury of severe acute pancreatitis and intervention of Xuebijing","volume":"10","author":"Kang","year":"2010","journal-title":"Chin. J. Pancreat. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"113301","DOI":"10.1016\/j.jep.2020.113301","article-title":"The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies and potential mechanisms","volume":"30","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jep.2018.05.043","article-title":"Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: a meta-analysis of randomized controlled trials","volume":"224","author":"Li","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.3748\/wjg.v23.i20.3615","article-title":"Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis","volume":"23","author":"Li","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-9905.2020.01.016","article-title":"Protective effect of Xuebijing Injection on lung injury in patients with severe acute pancreatitis","author":"Liu","year":"2020","journal-title":"Prog. Mod. general Surg. China.23"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.3390\/jcm11226696","article-title":"Xuebijing administration Alleviates pulmonary endothelial inflammation and coagulation dysregulation in the early Phase of sepsis in rats","volume":"11","author":"Lv","year":"2022","journal-title":"J. Clin. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3390\/biomedicines12112627","article-title":"Pancreatic morphology, Immunology, and the pathogenesis of acute pancreatitis","volume":"17","author":"Mihoc","year":"2024","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.phrs.2020.104654","article-title":"Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications","volume":"153","author":"Orgah","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/ptr.5653","article-title":"A pharmacological review of bioactive constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch","volume":"30","author":"Parker","year":"2016","journal-title":"Phytother. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MOG.0b013e328363e399","article-title":"New insights into the pathogenesis of pancreatitis","volume":"29","author":"Sah","year":"2013","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/gutjnl-2017-314657","article-title":"Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis","volume":"68","author":"Schepers","year":"2019","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/hpb.12259","article-title":"Early organ dysfunction affects long-term survival in acute pancreatitis patients","volume":"16","author":"Skouras","year":"2014","journal-title":"HPB Oxf. Sep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.biopha.2018.10.190","article-title":"Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations","volume":"109","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"118971","DOI":"10.1016\/j.carbpol.2021.118971","article-title":"The isolation, structural features and biological activities of polysaccharide from Ligusticum chuanxiong: a review","volume":"285","author":"Wang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1003-4706.2011.03.021","article-title":"Clinical study of ulinastatin combined with Xuebijing in the treatment of acute pancreatitis with lung injury","volume":"32","author":"Wangjue","year":"2011","journal-title":"J. Kunming Med. Coll."},{"key":"B29","doi-asserted-by":"publisher","first-page":"769190","DOI":"10.3389\/fphar.2021.769190","article-title":"Detecting critical functional ingredients group and mechanism of xuebijing injection in treating sepsis","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1875-5364(19)30010-x","article-title":"Danshen: a phytochemical and pharmacological overview","volume":"17","author":"Xd","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"854215","DOI":"10.3389\/fphar.2022.854215","article-title":"Network pharmacology and molecular docking to elucidate the potential mechanism of Ligusticum chuanxiong against osteoarthritis","volume":"13","author":"Xiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lers.2025.01.001","article-title":"A comprehensive step-by-step approach for the implementation of target trial emulation: Evaluating fluid resuscitation strategies in post-laparoscopic septic shock as an example","volume":"8","author":"Yang","year":"2025","journal-title":"Laparosc. Endosc. Robotic Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.joim.2023.08.004","article-title":"Xuebijing injection, a Chinese patent medicine, against severe pneumonia: current research progress and future perspectives","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Integr. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8824059","DOI":"10.1155\/2021\/8824059","article-title":"Analysis of the efficacy and mechanism of action of xuebijing injection on ARDS using meta-analysis and Network pharmacology","volume":"2021","author":"Zhang","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21037\/atm.2018.09.26","article-title":"A real-world study on adverse drug reactions to Xuebijing injection: hospital intensive monitoring based on 93 hospitals (31,913 cases)","volume":"7","author":"Zheng","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5847\/wjem.j.1920-8642.2024.016","article-title":"Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis","volume":"15","author":"Zhou","year":"2024","journal-title":"World J. Emerg. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"883729","DOI":"10.3389\/fphar.2022.883729","article-title":"Chinese herbal medicine xuebijing injection for acute pancreatitis: an overview of systematic reviews","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1549419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:27:00Z","timestamp":1744781220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1549419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":37,"alternative-id":["10.3389\/fphar.2025.1549419"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1549419","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"article-number":"1549419"}}